I agree that this site is using cookies. You can find further informations here.
X
Moore, KN
57  results:
Search for persons X
?
1

0311 DIFFERENCES IN ACTIVATION OF FEAR AND EXTINCTION CIRCU..:

Moore, KN ; Bottary, RM ; Gazecki, S...
Sleep.  40 (2017)  suppl_1 - p. A115-A115 , 2017
Link: https://doi.org/10.1093/..
 
?
2

Rucaparib: the past, present, and future of a newly approve..:

Dockery, LE ; Gunderson, CC ; Moore, KN
OncoTargets and Therapy.  10 (2017)  - p. 3029-3037 , 2017
Link: https://doi.org/10.2147/..
 
?
3

0419 HEMISPHERIC AND MORPHOLOGICAL CHARACTERISTICS OF SLEEP..:

Gazecki, S ; Bottary, RM ; Purcell, S...
Sleep.  40 (2017)  suppl_1 - p. A155-A155 , 2017
Link: https://doi.org/10.1093/..
 
?
4

Molecular Results and Potential Biomarkers Identified from ..:

Grisham, RN ; Vergote, I ; Banerjee, S...
728447.  , 2023
Link: https://repository.icr.a..
 
?
5

Overall Survival With Maintenance Olaparib at a 7-Year Foll..:

DiSilvestro, P ; Banerjee, S ; Colombo, N...
Obstetrical and Gynecological Survey, 2023, 78 (1), pp. 25 - 27.  , 2023
Link: https://repository.icr.a..
 
?
6

Low-grade serous ovarian cancer: expert consensus report on..:

Grisham, RN ; Slomovitz, BM ; Andrews, N...
ijgc-2023-004610.  , 2023
Link: https://repository.icr.a..
 
?
7

Trametinib versus standard of care in patients with recurre..:

Gershenson, DM ; Miller, A ; Brady, WE...
S0140-6736(21)02175-9.  , 2022
Link: https://repository.icr.a..
 
?
8

Overall Survival With Maintenance Olaparib at a 7-Year Foll..:

DiSilvestro, P ; Banerjee, S ; Colombo, N...
Journal of Clinical Oncology, 2022, pp. JCO2201549 -.  , 2022
Link: https://repository.icr.a..
 
?
9

Phase III, randomized trial of mirvetuximab soravtansine ve..:

Moore, KN ; Oza, AM ; Colombo, N...
Annals of oncology : official journal of the European Society for Medical Oncology, 2021, 32 (6), pp. 757 - 765.  , 2021
Link: https://repository.icr.a..
 
?
10

Utilizing an interim futility analysis of the OVAL study (V..:

Arend, RC ; Monk, BJ ; Herzog, TJ...
https://discovery.ucl.ac.uk/id/eprint/10124554/3/Ledermann_11.16.20_Revised_OVAL%20Interim%20Manuscript%20.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
11

Trametinib versus standard of care in patients with recurre..:

Gershenson, DM ; Miller, A ; Brady, WE...
The Lancet.  , 2021
Link: http://hdl.handle.net/10..
 
?
12

First-line PARP inhibitors in ovarian cancer: summary of an..:

Banerjee, S ; Gonzalez-Martin, A ; Harter, P...
ESMO open, 2020, 5 (6).  , 2021
Link: https://repository.icr.a..
 
?
13

PARPi after PARPi in epithelial ovarian cancer:

Essel, KG ; Behbakht, K ; Lai, T...
qt2ws494xs.  , 2021
Link: https://escholarship.org..
 
?
14

Imaging biomarkers of adiposity and sarcopenia as potential..:

Gillen, J ; Mills, KA ; Dvorak, J...
qt49z6t5fd.  , 2019
Link: https://escholarship.org..
 
?
15

Tissue response to applied loading using different designs ..:

Lemmens JMH ; Broadbridge J ; Macaulay M...
https://www.dovepress.com/tissue-response-to-applied-loading-using-different-designs-of-penile-c-peer-reviewed-article-MDER.  , 2019
Link: https://doaj.org/article..
 
1-15